Since ATXN3L regulates KLF5 at the protein level, it will be significant to develop a good anti-ATXN3L Ab to examine the ATXN3L protein expression in breast tumors in order to assess the clinical relevance of ATXN3L. This evidence concerns the gene KLF5 and breast neoplasm.